explore -WSS

explore

author：knowledge 2025-09-30 01:02:18 - browse：272

Photo illustration of newspaper clips written by Lawrence K Altman about presidents' health – opinion coverage from STAT — Alex Hogan/STAT

When I interviewed Ronald Reagan about his health in 1980, he was 69 and poised to become the oldest person to be elected president. During our conversation, Reagan was mentally sharp. In a light moment he feigned a wrenched back and asked what I (a physician) would do for it.

I asked him about his mother’s health, and he told me that his mother had symptoms suggestive of dementia before she died. I asked what he would do if, as president, he developed the same ailment, and how he would know he had it. His doctors would follow him, he said, and he would resign if they found evidence of cognitive decline. Years later, those remarks would seem particularly noteworthy.

The interview was likely the first in which a future president and his doctors discussed the leader’s health prospectively. (That cooperation was short-lived; Reagan’s aides did not allow reporters to interview him or his doctors when he ran for re-election after what some regarded as a poor debate performance with Walter Mondale.)

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Mystery swirls around US soldier who entered North Korea days ago, officials say

hotspot

WSS

'Golden Bachelor' Gerry Turner reveals what he wants in a partner and more

U.K. considers world's first use of meningitis vaccine to address gonorrhea

A woman pleads guilty to fire that kept a Wyoming abortion clinic from opening for a year

Are infertility treatments 'essential' during the Covid

Readout Newsletter: The latest at Gilead, Catalent, and the NIH

The stock market has soared this year, but will it last? Experts weigh in

knowledge

explore

hotspot

At least 13 dead in Texas as scorching temps continue

Eli Lilly to acquire DICE Therapeutics in $2.4 billion deal

Medicare details structure of new drug price negotiation program

Judge denies Trump's request for new trial in E. Jean Carroll case

Duchenne breakthrough therapy leaves behind pioneering families

'CMA Fest' 2023: How to watch, who is performing and more

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

U.K. considers world's first use of meningitis vaccine to address gonorrhea

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Morphosys mixed study results for blood cancer drug

focus

A daunting task: navigating dual Medicare, Medicaid eligibility

Astellas still sees hope in its gene therapy after four deaths

How a Boston hospital is priming medical residents to use GPT

Eli Lilly to acquire DICE Therapeutics in $2.4 billion deal

A daunting task: navigating dual Medicare, Medicaid eligibility

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

explore

hotspot

hotspot

Wikipedia